 Travis Redd
Concepts (186)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cornea | 10 | 2025 | 154 | 3.190 |
Why?
| | Eye Infections, Bacterial | 6 | 2024 | 45 | 2.400 |
Why?
| | Eye Infections, Fungal | 5 | 2024 | 20 | 1.990 |
Why?
| | Corneal Diseases | 4 | 2025 | 44 | 1.890 |
Why?
| | Ophthalmology | 4 | 2022 | 105 | 1.830 |
Why?
| | Artificial Intelligence | 5 | 2025 | 334 | 1.630 |
Why?
| | Keratitis | 2 | 2023 | 22 | 1.490 |
Why?
| | Refractive Surgical Procedures | 2 | 2022 | 7 | 1.440 |
Why?
| | Corneal Ulcer | 4 | 2024 | 21 | 1.250 |
Why?
| | Diagnostic Techniques, Ophthalmological | 3 | 2025 | 50 | 1.230 |
Why?
| | Keratoplasty, Penetrating | 3 | 2025 | 8 | 1.140 |
Why?
| | Epithelium, Corneal | 2 | 2025 | 44 | 1.120 |
Why?
| | Descemet Membrane | 1 | 2025 | 7 | 0.930 |
Why?
| | Re-Epithelialization | 1 | 2025 | 8 | 0.930 |
Why?
| | Trachoma | 1 | 2024 | 2 | 0.900 |
Why?
| | Rosacea | 2 | 2022 | 2 | 0.880 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2024 | 90 | 0.830 |
Why?
| | Keratitis, Herpetic | 1 | 2023 | 2 | 0.820 |
Why?
| | Retinopathy of Prematurity | 3 | 2021 | 161 | 0.780 |
Why?
| | Herpes Simplex | 1 | 2023 | 95 | 0.760 |
Why?
| | DNA, Fungal | 1 | 2022 | 80 | 0.710 |
Why?
| | Metagenome | 1 | 2022 | 152 | 0.680 |
Why?
| | DNA, Bacterial | 1 | 2022 | 339 | 0.650 |
Why?
| | Myopia | 1 | 2020 | 55 | 0.620 |
Why?
| | Glaucoma | 1 | 2022 | 241 | 0.620 |
Why?
| | Bartonella Infections | 1 | 2019 | 5 | 0.610 |
Why?
| | Retinal Artery Occlusion | 1 | 2019 | 10 | 0.600 |
Why?
| | Electronic Health Records | 3 | 2017 | 1122 | 0.590 |
Why?
| | Meaningful Use | 1 | 2015 | 13 | 0.480 |
Why?
| | Telemedicine | 3 | 2021 | 891 | 0.470 |
Why?
| | ROC Curve | 5 | 2024 | 586 | 0.470 |
Why?
| | Fungi | 3 | 2022 | 152 | 0.470 |
Why?
| | Fluorescein Angiography | 4 | 2022 | 175 | 0.450 |
Why?
| | Tomography, Optical Coherence | 4 | 2022 | 257 | 0.420 |
Why?
| | Photography | 3 | 2024 | 115 | 0.410 |
Why?
| | Efficiency, Organizational | 1 | 2014 | 139 | 0.410 |
Why?
| | Health Plan Implementation | 1 | 2014 | 145 | 0.410 |
Why?
| | Visual Acuity | 5 | 2025 | 443 | 0.400 |
Why?
| | Physicians, Primary Care | 1 | 2015 | 226 | 0.380 |
Why?
| | Humans | 36 | 2025 | 141187 | 0.360 |
Why?
| | Academic Medical Centers | 1 | 2014 | 528 | 0.350 |
Why?
| | Blindness | 2 | 2020 | 48 | 0.310 |
Why?
| | Ophthalmoscopy | 2 | 2018 | 38 | 0.290 |
Why?
| | Eyelids | 2 | 2024 | 43 | 0.260 |
Why?
| | Bacteria | 3 | 2024 | 881 | 0.260 |
Why?
| | Conjunctivitis, Viral | 2 | 2024 | 3 | 0.260 |
Why?
| | Pediatrics | 1 | 2014 | 1094 | 0.250 |
Why?
| | Ulcer | 2 | 2024 | 34 | 0.250 |
Why?
| | Sensitivity and Specificity | 4 | 2024 | 1973 | 0.240 |
Why?
| | Prevalence | 2 | 2024 | 2772 | 0.240 |
Why?
| | Anterior Eye Segment | 1 | 2024 | 11 | 0.220 |
Why?
| | Ethiopia | 1 | 2024 | 41 | 0.220 |
Why?
| | Reproducibility of Results | 5 | 2024 | 3348 | 0.220 |
Why?
| | Male | 19 | 2025 | 69783 | 0.220 |
Why?
| | Cicatrix | 2 | 2023 | 67 | 0.220 |
Why?
| | Conjunctiva | 1 | 2024 | 53 | 0.220 |
Why?
| | Area Under Curve | 2 | 2021 | 324 | 0.210 |
Why?
| | Microscopy, Confocal | 1 | 2024 | 324 | 0.200 |
Why?
| | Simplexvirus | 1 | 2023 | 82 | 0.200 |
Why?
| | Conjunctival Diseases | 1 | 2023 | 21 | 0.200 |
Why?
| | Keratoconjunctivitis | 1 | 2023 | 11 | 0.200 |
Why?
| | Tetracycline | 1 | 2022 | 14 | 0.200 |
Why?
| | Infant, Newborn | 4 | 2024 | 6275 | 0.190 |
Why?
| | Immunologic Deficiency Syndromes | 1 | 2023 | 72 | 0.190 |
Why?
| | Cross-Sectional Studies | 3 | 2024 | 5636 | 0.190 |
Why?
| | Eyelid Diseases | 1 | 2023 | 23 | 0.190 |
Why?
| | Child | 6 | 2024 | 22308 | 0.190 |
Why?
| | Technology | 1 | 2022 | 94 | 0.190 |
Why?
| | Cat-Scratch Disease | 1 | 2022 | 3 | 0.180 |
Why?
| | Expert Systems | 1 | 2021 | 4 | 0.180 |
Why?
| | Infant | 3 | 2025 | 9818 | 0.180 |
Why?
| | Skin Diseases | 1 | 2023 | 147 | 0.180 |
Why?
| | Parking Facilities | 1 | 2021 | 1 | 0.180 |
Why?
| | Female | 19 | 2024 | 75515 | 0.170 |
Why?
| | Point-of-Care Testing | 1 | 2021 | 35 | 0.170 |
Why?
| | Imaging, Three-Dimensional | 1 | 2024 | 567 | 0.170 |
Why?
| | Azithromycin | 1 | 2021 | 98 | 0.170 |
Why?
| | Specialization | 1 | 2021 | 130 | 0.170 |
Why?
| | Corneal Neovascularization | 1 | 2020 | 16 | 0.160 |
Why?
| | Specimen Handling | 1 | 2022 | 182 | 0.160 |
Why?
| | Microsurgery | 1 | 2020 | 77 | 0.160 |
Why?
| | Eye Diseases | 1 | 2021 | 92 | 0.160 |
Why?
| | Education, Distance | 1 | 2020 | 56 | 0.160 |
Why?
| | Suture Techniques | 1 | 2020 | 128 | 0.160 |
Why?
| | Aged, 80 and over | 6 | 2022 | 7856 | 0.160 |
Why?
| | Mycoses | 1 | 2020 | 85 | 0.150 |
Why?
| | Antifungal Agents | 1 | 2020 | 144 | 0.150 |
Why?
| | Bartonella | 1 | 2019 | 8 | 0.150 |
Why?
| | Chorioretinitis | 1 | 2019 | 8 | 0.150 |
Why?
| | Retina | 1 | 2022 | 314 | 0.150 |
Why?
| | Retinitis | 1 | 2019 | 21 | 0.150 |
Why?
| | Intraocular Pressure | 1 | 2021 | 315 | 0.150 |
Why?
| | Blood Vessels | 1 | 2020 | 180 | 0.150 |
Why?
| | Wound Healing | 1 | 2021 | 348 | 0.140 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2022 | 546 | 0.140 |
Why?
| | Infant, Low Birth Weight | 1 | 2018 | 146 | 0.140 |
Why?
| | Optic Nerve | 1 | 2017 | 66 | 0.130 |
Why?
| | Adult | 12 | 2024 | 39177 | 0.130 |
Why?
| | Diagnosis, Differential | 1 | 2021 | 1498 | 0.130 |
Why?
| | Retinal Vessels | 1 | 2017 | 75 | 0.130 |
Why?
| | Practice Patterns, Physicians' | 2 | 2017 | 1336 | 0.130 |
Why?
| | Uveitis | 1 | 2017 | 148 | 0.120 |
Why?
| | Severity of Illness Index | 2 | 2021 | 2892 | 0.120 |
Why?
| | Middle Aged | 10 | 2024 | 34434 | 0.120 |
Why?
| | Attitude to Computers | 1 | 2015 | 29 | 0.120 |
Why?
| | Pediatricians | 1 | 2017 | 131 | 0.110 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2015 | 101 | 0.110 |
Why?
| | Choroidal Neovascularization | 1 | 2015 | 57 | 0.110 |
Why?
| | Wet Macular Degeneration | 1 | 2015 | 57 | 0.110 |
Why?
| | Child, Preschool | 3 | 2024 | 11457 | 0.110 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2015 | 198 | 0.110 |
Why?
| | Anti-Bacterial Agents | 2 | 2022 | 1865 | 0.110 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2015 | 228 | 0.110 |
Why?
| | Young Adult | 5 | 2022 | 13673 | 0.100 |
Why?
| | Medicine | 1 | 2015 | 125 | 0.100 |
Why?
| | Biomarkers | 1 | 2024 | 4174 | 0.100 |
Why?
| | Pandemics | 1 | 2021 | 1653 | 0.090 |
Why?
| | India | 2 | 2024 | 208 | 0.090 |
Why?
| | Aged | 6 | 2022 | 24574 | 0.090 |
Why?
| | Registries | 1 | 2019 | 2135 | 0.080 |
Why?
| | Internship and Residency | 1 | 2020 | 1235 | 0.080 |
Why?
| | Fundus Oculi | 2 | 2020 | 86 | 0.070 |
Why?
| | Attitude of Health Personnel | 1 | 2017 | 1171 | 0.070 |
Why?
| | Health Personnel | 1 | 2014 | 737 | 0.070 |
Why?
| | Adolescent | 3 | 2022 | 22007 | 0.070 |
Why?
| | Physicians | 1 | 2015 | 934 | 0.060 |
Why?
| | Gestational Age | 2 | 2021 | 957 | 0.060 |
Why?
| | Predictive Value of Tests | 2 | 2021 | 2070 | 0.060 |
Why?
| | Corneal Topography | 1 | 2024 | 25 | 0.060 |
Why?
| | Retrospective Studies | 5 | 2022 | 16273 | 0.060 |
Why?
| | Prospective Studies | 3 | 2024 | 7739 | 0.060 |
Why?
| | Conjunctivitis, Bacterial | 1 | 2024 | 13 | 0.050 |
Why?
| | Tomography | 1 | 2024 | 45 | 0.050 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2024 | 346 | 0.050 |
Why?
| | Rubella virus | 1 | 2023 | 9 | 0.050 |
Why?
| | Cyclosporine | 1 | 2024 | 265 | 0.050 |
Why?
| | Hypesthesia | 1 | 2023 | 19 | 0.050 |
Why?
| | Tetracyclines | 1 | 2022 | 13 | 0.050 |
Why?
| | Granuloma | 1 | 2023 | 97 | 0.050 |
Why?
| | Macrolides | 1 | 2022 | 67 | 0.050 |
Why?
| | Slit Lamp Microscopy | 1 | 2021 | 3 | 0.050 |
Why?
| | Acute Disease | 1 | 2024 | 1008 | 0.040 |
Why?
| | False Positive Reactions | 1 | 2021 | 125 | 0.040 |
Why?
| | Hospital Units | 1 | 2021 | 32 | 0.040 |
Why?
| | Multimodal Imaging | 1 | 2022 | 120 | 0.040 |
Why?
| | Sutures | 1 | 2021 | 60 | 0.040 |
Why?
| | United States | 2 | 2017 | 15220 | 0.040 |
Why?
| | Natamycin | 1 | 2020 | 1 | 0.040 |
Why?
| | Corneal Perforation | 1 | 2020 | 1 | 0.040 |
Why?
| | Injections, Intraocular | 1 | 2020 | 13 | 0.040 |
Why?
| | Symptom Assessment | 1 | 2021 | 129 | 0.040 |
Why?
| | Treatment Failure | 1 | 2021 | 354 | 0.040 |
Why?
| | Voriconazole | 1 | 2020 | 21 | 0.040 |
Why?
| | Corneal Stroma | 1 | 2020 | 24 | 0.040 |
Why?
| | Glucocorticoids | 1 | 2024 | 533 | 0.040 |
Why?
| | Workflow | 1 | 2021 | 171 | 0.040 |
Why?
| | Oregon | 1 | 2019 | 78 | 0.040 |
Why?
| | Immunosuppressive Agents | 1 | 2024 | 854 | 0.040 |
Why?
| | Administration, Oral | 1 | 2021 | 803 | 0.040 |
Why?
| | Anti-Inflammatory Agents | 1 | 2022 | 482 | 0.040 |
Why?
| | Linear Models | 1 | 2021 | 857 | 0.040 |
Why?
| | Triage | 1 | 2021 | 246 | 0.040 |
Why?
| | Swine | 1 | 2020 | 806 | 0.030 |
Why?
| | Infant, Very Low Birth Weight | 1 | 2018 | 70 | 0.030 |
Why?
| | Outpatients | 1 | 2021 | 420 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2021 | 339 | 0.030 |
Why?
| | Educational Measurement | 1 | 2020 | 318 | 0.030 |
Why?
| | Time Factors | 2 | 2020 | 6956 | 0.030 |
Why?
| | Observer Variation | 1 | 2018 | 355 | 0.030 |
Why?
| | Physical Examination | 1 | 2018 | 241 | 0.030 |
Why?
| | Medical History Taking | 1 | 2017 | 116 | 0.030 |
Why?
| | Oxygen | 1 | 2021 | 993 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2020 | 1983 | 0.030 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2018 | 268 | 0.030 |
Why?
| | Health Care Surveys | 1 | 2017 | 565 | 0.030 |
Why?
| | Algorithms | 1 | 2021 | 1763 | 0.030 |
Why?
| | Infant, Premature | 1 | 2018 | 597 | 0.030 |
Why?
| | Odds Ratio | 1 | 2015 | 1052 | 0.020 |
Why?
| | Incidence | 1 | 2019 | 2794 | 0.020 |
Why?
| | Clinical Competence | 1 | 2020 | 1202 | 0.020 |
Why?
| | Inflammation | 1 | 2023 | 2890 | 0.020 |
Why?
| | Prognosis | 1 | 2020 | 4073 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2017 | 5200 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2015 | 3588 | 0.020 |
Why?
| | Risk Factors | 1 | 2015 | 10438 | 0.010 |
Why?
| | Animals | 1 | 2020 | 37657 | 0.010 |
Why?
|
|
Redd's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|